Literature DB >> 3068270

Cardiac arrest due to oral potassium intake.

H J Schim van der Loeff1, R J Strack van Schijndel, L G Thijs.   

Abstract

A 29-year-old woman suffered a cardiac arrest, due to profound hyperkalaemia, caused by the use of a potassium-containing salt substitute. She was resuscitated, but post-hypoxic brain damage occurred. Some of the sparse literature is reviewed.

Entities:  

Mesh:

Year:  1988        PMID: 3068270     DOI: 10.1007/bf00255641

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  5 in total

1.  Near-fatal hyperkalemia due to ingestion of salt substitute by an infant.

Authors:  R J Kallen; C H Rieger; H S Cohen; M A Sutter; R T Ong
Journal:  JAMA       Date:  1976-05-10       Impact factor: 56.272

2.  Hyperkalemia due to salt substitutes.

Authors:  R E Hoyt
Journal:  JAMA       Date:  1986-10-03       Impact factor: 56.272

3.  Suicide by oral ingestion of a potassium preparation.

Authors:  M Kaplan
Journal:  Ann Intern Med       Date:  1969-08       Impact factor: 25.391

4.  Fatal hyperkalemia from accidental overdose of potassium chloride.

Authors:  C V Wetli; J H Davis
Journal:  JAMA       Date:  1978-09-22       Impact factor: 56.272

5.  Rapid poisoning with slow-release potassium.

Authors:  R N Illingworth; A T Proudfoot
Journal:  Br Med J       Date:  1980-08-16
  5 in total
  3 in total

Review 1.  Acute oral potassium overdose: the role of hemodialysis.

Authors:  George M Bosse; Melissa A Platt; Stephen D Anderson; Michael W Presley
Journal:  J Med Toxicol       Date:  2011-03

2.  Hyperkalemia from Dietary Supplements.

Authors:  Vivek Batra; Vipin Villgran
Journal:  Cureus       Date:  2016-11-02

Review 3.  Systematic review and meta-analysis of randomised controlled trials on the effects of potassium supplements on serum potassium and creatinine.

Authors:  Francesco P Cappuccio; Laura A Buchanan; Chen Ji; Alfonso Siani; Michelle A Miller
Journal:  BMJ Open       Date:  2016-08-26       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.